Concepedia

Clara‐Maria Scarlata

CS

Statistics

Publications

9

Citations

875

H-Index

9

Active since

2014

Affiliations

Centre de Recherches en Cancérologie de Toulouse(Current)

Inserm

Université Toulouse III - Paul Sabatier

Institut universitaire du cancer de Toulouse Oncopole

Centre National de la Recherche Scientifique

Clara‐Maria Scarlata is an author at Centre de Recherches en Cancérologie de Toulouse specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2014–2023

9

Publications

9

Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

Aurélie Fluckiger, Romain Daillère, Mohamed Sassi et al. · Science · 2020 · 384 citations · Full text

, , +17

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Marianne Weulersse, Assia Asrir, Andrea Pichler et al. · Immunity · 2020 · 139 citations · Full text

, , +14

PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells

Camille-Charlotte Balança, Anna Salvioni, Clara‐Maria Scarlata et al. · JCI Insight · 2020 · 139 citations · Full text

, , +17

Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells

Don‐Marc Franchini, Olivia Lanvin, Marie Tosolini et al. · Cell Reports · 2019 · 57 citations · Full text

, , +17

Expression of MAGE-A3/6 in Primary Breast Cancer is Associated With Hormone Receptor Negative Status, High Histologic Grade, and Poor Survival

Maha Ayyoub, Clara‐Maria Scarlata, Ahmed Hamaï et al. · Journal of Immunotherapy · 2014 · 48 citations

, , +17

1–5 of 9